Gao et al.44has found that RORα, through the SIRT1 molecule, can inhibit the nuclear factor kappa B (NF‐κB) pathway, thus playing an anti‐inflammatory role in inflammatory bowel disease. Here, NFKB1 is linked to inflammatory bowel disease.